1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients (n = =40) | ||||||||||||
1 | MARS-5 (TP2) | 1 | ||||||||||
2 | PCS (TP2) | −.01 | 1 | |||||||||
3 | MCS (TP2) | −.01 | .15 | 1 | ||||||||
4 | Illness perceptions (BIPQ) | .02 | .20 | −.34* | 1 | |||||||
5 | Necessity (BCRQ) | −.22 | −.04 | −.28 | .27 | 1 | ||||||
6 | Exercise concerns (BCRQ) | −.05 | −.35* | −.45* | .15 | .06 | 1 | |||||
7 | Barriers (BCRQ) | −.10 | −.26 | −.28 | .17 | −.14 | .53** | 1 | ||||
8 | Suitability (BCRQ) | .07 | −.15 | −.07 | −.02 | −.17 | .65** | .68** | 1 | |||
9 | MARS-5 | .29 | .09 | .01 | −.11 | −.11 | −.11 | −.23* | −.02 | 1 | ||
10 | PCS | −.19 | .32* | .08 | .27 | −.01 | −.32* | .09 | −.02 | −.01 | 1 | |
11 | MCS | .20 | .35* | .59** | −.42** | .35* | −.43* | −.20 | −.40 | .11 | −.11 | 1 |